Reduced emergency department use among insured individuals receiving extended-release buprenorphine in a health system setting

This publication has 23 references indexed in Scilit:

• Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies
  The Lancet Psychiatry, 2023
• Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings
  Journal of Addiction Medicine, 2022
• Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study
  Journal of Addiction Medicine, 2020
• Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study
  Journal of Substance Abuse Treatment, 2020
• Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study
  Journal of Addiction Medicine, 2019
• Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
  The Lancet, 2019
• Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder
  JAMA Internal Medicine, 2018
• Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis
  Drug and Alcohol Dependence, 2016
• Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis
  Drug and Alcohol Dependence, 2016
• Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
  New England Journal of Medicine, 2003